Current Trials and Future Indications for LAAC: The Essentials
Presenter
Molly Szerlip, M.D., FSCAI, Baylor Scott & White The Heart Hospital - Plano, Richardson, TX
Molly Szerlip, M.D., FSCAI, Baylor Scott & White The Heart Hospital - Plano, Richardson, TX
Learning Objectives:
- Compare and contrast CHAMPION and CATALYST trials and estimate impact if noninferiority is found (early data on patient preference in low bleeding risk patients?) Displaying a case from a trial (3 slides, including implant) will help illustrate
- Review ongoing trials of new devices
- Analyze what it may mean for an LAAC practice if all AF patients are offered device? Thinking from a systems perspective, including the need to train new operators
Keywords: Left Atrial Appendage Closure (LAAC) and Structural Heart Disease (SHD)